Medical responsible for Breast cancer (Kadcyla, Perjeta, Herclon) and Hemato-oncology portfolio (Ristova, Gazyva)Medical lead for APHINITY launch (Perjeta in adjuvant setting for eBC,), KATHERINE launch (Kadcyla in adjuvant setting for eBC).Built scientific partnership and advocacy with leading HCOs and TAEs through high value medical programs.Medical support to Access team, marketing team for implementing access projects, marketing campaigns, brand literature, PSP roll out… Show more Medical responsible for Breast cancer (Kadcyla, Perjeta, Herclon) and Hemato-oncology portfolio (Ristova, Gazyva)Medical lead for APHINITY launch (Perjeta in adjuvant setting for eBC,), KATHERINE launch (Kadcyla in adjuvant setting for eBC).Built scientific partnership and advocacy with leading HCOs and TAEs through high value medical programs.Medical support to Access team, marketing team for implementing access projects, marketing campaigns, brand literature, PSP roll out etc.Collaborated with the regulatory team for NDA approvals, SEC presentations, regulatory dossier compilation. Medical support for the clinical trials in the therapy area. Community of Practice (COP) Expert for i7 countries for pertuzumab reimbursement in eBC.Led the medical affairs team during Group Audit, with no critical or major findings. Show less

Medical Monitoring plan and review of trial data.Protocol, SAP, ICF, CSR review.Project Manager for Portfolio Prioritization committee to review and recommend pipeline molecules for launch.SPOC for Grants & Donations assessment and strategic deployment

Clinical Research (Phase I to IV)Patient carePeople managementSubject Expert Committee regulatory dossier review